September 22, 2022

Odyssey Therapeutics Named to 2022 Endpoints 11

Boston, Mass., September 22, 2022 — Odyssey Therapeutics, Inc., a biotechnology company pioneering next generation precision immunomodulators and oncology medicines, today announced that it is has been named by Endpoints News as one of the Endpoints 11 companies of 2022. This honor is awarded to the most promising private biotechnology companies in the industry breaking new ground in drug development.

Odyssey’s highly integrated drug hunting engine fuses both established and newly-emerging drug discovery technologies to tackle immunology and oncology targets with the highest clinical and commercial potential, including those previously considered “undruggable.” The company’s platform approach aims to transform drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients.

“We are honored to be recognized as an Endpoints 11 company for our suite of cutting-edge technology platforms and portfolio of innovative product candidates to deliver differentiated patient benefits with an eye to transforming standards of care,” said Gary D. Glick, Ph.D., Founder and Chief Executive Officer of Odyssey Therapeutics. “This recognition serves as a testament to the tireless work and dedication of our team in delivering on our mission to provide life-changing solutions for patients, and continues to fuel our urgency to go beyond the current limitations of treatment and make the future of precision medicine a reality.”

About Odyssey Therapeutics

Odyssey Therapeutics is a biotechnology company dedicated to discovering, developing, and commercializing immunomodulators and oncology medicines that aim to transform drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. Built from the ground-up by an expert team of drug hunters, scientists and industry leaders, Odyssey is focused on being first to market with programs that act on targets with the highest clinical and commercial potential. For more information, please visit www.odysseytx.com and follow Odyssey Therapeutics on Twitter (@Odyssey_Tx) and LinkedIn.

Media Contact

[email protected]

Careers

Extraordinary Leaps, Together

Our team’s ambition to make a meaningful impact in health is underscored by the foundational values that drive us to do our best work. At Odyssey, we believe:

We’ll succeed if we honor the patient

We’ll win if we act with urgency

We’ll advance if we respect the science

We’ll prevail if wedo what’s right

We’ll thrive if we raise each other up

We’ll prosper if we own our success

Benefits

Odyssey’s comprehensive benefits are designed to fit individual needs and provide the resources to support our employees’ growth and development.*

Medical, dental, and vision insurance
Prescription coverage
Health savings account with company contribution
Dependent care account
Life insurance
Short- and long-term disability
Flexible time off
Mentoring and career development programs
Ability to work across company sites in US and Europe

*Benefits vary by region.

Explore our open positions

Extraordinary leaps are accomplished with the help of the best, the brightest, and the most inventive minds driven to solve the greatest challenges.

Are you interested in joining a collaborative, global team of forward-thinking innovators united by a vision to reimagine the way drugs are discovered? Do you want to be part of a company that is catalyzing the future of precision medicine to improve the lives of patients living with inflammatory diseases and cancer? If so, we’d love to hear from you.

© Odyssey Therapeutics 2023. All rights reserved.